Clinical Trial Update: A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma [Phase 2]

View source ↗

Summary

Phase II study evaluating isolated hepatic perfusion for ocular melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Ocular Melanoma

Drugs mentioned

• Isolated Hepatic Perfusion (IHP)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma | Phase 2 | Status: COMPLETED